Dr. Carla Fisher is a fellowship-trained breast surgeon who specializes in all aspects of both benign and malignant breast disease. She sees patients at the Rena Rowan Breast Center housed in the Abramson Cancer Center along with a multidisciplinary team that includes medical oncology, radiation oncology, breast radiology, and surgical nurse practitioners.

Dr. Fisher completed her undergraduate studies at the Pennsylvania State University and received her medical degree from the University of Pennsylvania School of Medicine. She fulfilled a general surgery residency at the Medical University of South Carolina in Charleston and a fellowship in breast oncology at the Washington University School of Medicine.

American Society of Breast Surgeons

1. Fisher CS, Baker MK. Improving participation and quality of clinical research in a university based General Surgery residency program. American Surgeon 76(7):741-742, July 2010.
2. Fisher CS, Cole DJ, Mitas M, Garrett-Meyer E, Metcalf JS, Gillanders WE, Mikhitarian K, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, El-Sheemy M, Orr RK, Valle AA, Henderson MA, Dewitty RL, Sugg SL, Frykberg E, Yeh K, Bell RM, Baker MK. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: A final analysis of a prospective multi-institutional cohort study. Annals of Surgical Oncology 17(Suppl 3):312-320, Oct. 2010.
3. Fisher CS, Watchel MS, Margenthaler JA. Outcomes for patients who develop both breast and colorectal cancer. Annals of Surgical Oncology 2011 (in press).
4. Fisher CS, Ma CX, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA. Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple negative breast cancer only after a complete pathologic response. Presented at the Society of Surgical Oncology Annual Meeting, San Antonio, TX, Mar. 2011. Annals or Surgical Oncology 2011, (in press)
5. Fisher CS, Klimberg VS, Khan S, Gao F, Margenthaler JA. Margin index is not a reliable tool in predicting residual disease after breast-conserving surgery for DCIS. Oral presentation at the American Society of Breast Surgeons Annual Meeting, Washington, DC, May 2011. Annals or Surgical Oncology 2011, (in press)
6. Fisher CS, Margenthaler JA. A look into the ductoscope: Its role in pathologic nipple discharge. Presented at the American Society of Breast Surgeons Annual Meeting, Washington, DC, May 2011. Annals or Surgical Oncology 2011, (in press)
7. Fisher CS, Mushawah FA, Gao F, Margenthaler JA. Ultrasound-guided lumpectomy for palpable breast cancers. Presented at the American Society of Breast Surgeons Annual Meeting, Washington, DC, May 2011. Annals or Surgical Oncology 2011, (in press)

1. Fisher CS, Morgan K, Adams D. Nesidioblastosis following Roux-en-Y gastric bypass: A difficult balance. Presented at the Southeastern Surgical Congress Annual Meeting, Atlanta, GA, Feb. 2009.
2. Morgan KA, Fisher CS, Adams DB. Nesidioblastosis following Roux-en-Y gastric bypass: A difficult balance. Presented at the Pancreas Club, Inc. Annual Meeting, Chicago, IL, May 2009.
3. Fisher CS, Morgan K, Adams D. Nesidioblastosis following Roux-en-Y gastric bypass: A difficult balance. Presented at the Resident Appreciation Day, Medical University of South Carolina, Charleston, SC, June 2009.
4. Fisher CS, Baker MK. Improving participation and quality of clinical research in a university based General Surgery residency program. Presented at the Southeastern Surgical Congress Annual Meeting, Savannah, GA, Feb. 2010.
5. Fisher CS, Cole DJ, Mitas M, Mikhitarian K, Garrett-Mayer EL, Baker MK. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: A final analysis of a prospective multi-institutional cohort study. Oral presentation at the American Society of Breast Surgeons Annual Meeting, Las Vegas, NV, May 2010.
6. Fisher CS, Adams DB, Morgan KA. War wounds of the pancreas: A case report from Iraq. Presented at the Southeastern Surgical Congress Annual Meeting, Savannah, GA, Feb. 2010, and published in American Surgeon 76:E63-64, 2010.
7. Fisher CS, Cole DJ, Mitas M, Mikhitarian K, Garrett-Mayer EL, Baker MK. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: A final analysis of a prospective multi-institutional cohort study. Oral presentation at the American Society of Breast Surgeons Annual Meeting, Las Vegas, NV, May 2010.
8. Fisher CS, Watchel MS, Margenthaler JA. Outcomes for patients who develop both breast and colorectal cancer. Presented at the Society of Surgical Oncology Annual Meeting, San Antonio, TX, Mar. 2011.
9. Fisher CS, Ma CX, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA. Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple negative breast cancer only after a complete pathologic response. Abstract of distinction approved for presentation at the Missouri Chapter of the American College of Surgeons, Lake of the Ozarks, MO, June 2011.
10. Fisher CS, Klimberg VS, Khan S, Gao F, Margenthaler JA. Margin index is not a reliable tool in predicting residual disease after breast-conserving surgery for DCIS. Approved for presentation at the Missouri Chapter of the American College of Surgeons, Lake of the Ozarks, MO, June 2011.